title: Plasma 13,14-dihydro-15-keto-prostaglandin F2 alpha concentrations in prepubertal dairy heifers challenged with oxytocin.
abstract: Twenty-nine prepubertal Holstein heifers were assigned by age to one of three age groups to determine if the prepubertal bovine uterus could respond to an oxytocin stimulus. Group 1 heifers were 6 to 7 months of age (AGE1; n = 11), group 2 heifers were 8 to 9 months of age (AGE2; n = 11) and group 3 heifers were 10 to 11 months of age (AGE3; n = 7). Blood samples were collected via an indwelling jugular catheter. Four samples were collected at 15-min intervals prior to oxytocin administration to determine basal 13,14-dihydro-15-keto-prostaglandin F2 alpha (PGFM) concentrations. Each heifer received 100 IU of oxytocin i.v., blood sampling continued at 5 min intervals for the next 30 min and for an additional 90 min at 15-min intervals. Heifers were considered responders to oxytocin if mean PGFM concentrations increased at least 1.5 times the SD of their basal PGFM concentration. Age of the heifer (P less than .0001) and responder status (P less than .05) affected plasma PGFM. Plasma PGFM was higher in AGE1 and AGE3 heifers than AGE2 (P less than .0001). The number of responders was greatest at AGE3 (P less than .03) with AGE1 and AGE2 being similar. Mean basal PGFM was lower (P less than .04) at AGE2 than AGE1 with AGE3 being intermediate. In addition, basal PGFM at AGE1 tended to be lower (P less than .08) in the responders than in the non-responders, while AGE2 basal PGFM did not differ between responders and non-responders (P greater than .10).(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Texas A&M University, Agricultural Research and Extension Center, Overton 75684.
authors.forename: R P
authors.initials: RP
authors.lastname: Del Vecchio
authors.forename: D A
authors.initials: DA
authors.lastname: Neuendorff
authors.forename: R D
authors.initials: RD
authors.lastname: Randel
mesh_terms: D000367:Age Factors; D000818:Animals; D002417:Cattle / Q000502:physiology*; D015237:Dinoprost / Q000031:analogs & derivatives* / Q000097:blood; D005260:Female; D010121:Oxytocin / Q000494:pharmacology*; D012741:Sexual Maturation / Q000502:physiology*; D014599:Uterus / Q000187:drug effects* / Q000378:metabolism
chemical_list: C008228:15-keto-13,14-dihydroprostaglandin F2alpha; D010121:Oxytocin; D015237:Dinoprost